Liothyronine (T3) and Tirzepatide Interaction

Monitor
Mechanism-based 50% confidence

Liothyronine (T3) and Tirzepatide have an interaction requiring monitoring for interaction with 50% confidence. Both Liothyronine (T3) and Tirzepatide promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Liothyronine (T3)

Thyroid Hormone | Metabolic Optimization

Liothyronine enters target cells via monocarboxylate transporter 8 (MCT8) and other thyroid hormone transporters, then binds to nuclear thyroid hormone receptors (primarily TR-beta in metabolic tissues and TR-alpha in cardiac tissue). The T3-receptor complex forms heterodimers with retinoid X receptors (RXR) and binds to thyroid hormone response elements (TREs) on DNA, directly modulating gene transcription.

Half-life: ~1 day Typical dose: 25-75 mcg/day (replacement) metabolic, weight loss
thyroid receptor blood pressure raisingcardiotoxic
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Frequently Asked Questions

Can I take Liothyronine (T3) with Tirzepatide?

Yes, but with caution. Both Liothyronine (T3) and Tirzepatide promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. Regular monitoring is advised.

Is Liothyronine (T3) and Tirzepatide safe together?

Based on pharmacological analysis, this combination is considered monitor. No critical safety flags identified for this pair.

What are the interactions between Liothyronine (T3) and Tirzepatide?

Both Liothyronine (T3) and Tirzepatide promote fat breakdown. While additive fat loss is possible, excessive lipolysis can cause rapid free fatty acid elevation and cardiac strain. Monitor heart rate and adjust doses gradually. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.

How should I time Liothyronine (T3) and Tirzepatide?

Liothyronine (T3) has a half-life of ~1 day and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Liothyronine (T3) vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.